Proof-of-concept trial in a single patient shows that cells can survive transplantation without immunosuppression ...

Add Yahoo as a preferred source to see more of our stories on Google. This article is part of “Innovations In: Type 1 Diabetes,” an editorially independent special report that was produced with ...

Researchers are developing a two-part therapy for type 1 diabetes: lab-made insulin-producing cells paired with ...

Our body controls the levels of sugar in our blood with a hormone called insulin, which is made by beta cells in the pancreas. In type 1 diabetes, the immune system erroneously attacks those beta ...

Researchers engineered immune cells that protect insulin-producing cell transplants, bringing scientists closer to a cure for type 1 diabetes.

A new gene therapy approach aimed at protecting people with type 1 diabetes from developing diabetic kidney disease—a serious and common complication of the condition, has shown promising results in a ...

Scientists at the University of Wisconsin–Madison have uncovered a possible way to protect key cells in the pancreas that are targeted during the development of Type 1 diabetes. Subscribe to our ...

This article is part of “Innovations In: Type 1 Diabetes,” an editorially independent special report that was produced with financial support from Vertex. In 2024 Stephen Rich and his colleagues ...

Obviously caveats must be drawn from a mouse model such as this, but the results have supercharged the team's determination.

Researchers identify genetic markers that predict the rate of β-cell failure in type 1 diabetes, facilitating earlier, personalized care strategies Type 1 diabetes (T1D) is an autoimmune condition ...

At the Medical University of South Carolina (MUSC), researcher Leonardo Ferreira, Ph.D., is leading an ambitious effort to change how type 1 diabetes ...

A test using genetics to predict who is at the highest risk of developing type 1 diabetes could one day be applied to largescale health studies, to identify adults who could benefit from new drugs, ...